2014
DOI: 10.1074/jbc.m114.552380
|View full text |Cite
|
Sign up to set email alerts
|

Crystal Structure of the Dithiol Oxidase DsbA Enzyme from Proteus Mirabilis Bound Non-covalently to an Active Site Peptide Ligand

Abstract: Background: DsbA enzymes assemble bacterial virulence factors and are targets for an entirely new drug class. Results: Proteus mirabilis DsbA was characterized and its structure determined with a peptide bound non-covalently at the active site. Conclusion:The structure provides an important basis for future inhibitor design. Significance: New drugs to treat superbugs are urgently needed. DsbA inhibitors could have antivirulence activity against bacterial pathogens.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
38
0
4

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
1
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(43 citation statements)
references
References 76 publications
1
38
0
4
Order By: Relevance
“…Although PDI obtained near-unity amplitude as well, the fractional occurrence of reduced domains due to DsbA activity levels off at 0.44. We cite this observation as evidence of non-covalent interactions between unfolded substrate and enzyme, which have been described previously by others but remain poorly understood (17). The non-covalent interactions stabilize a previously unconsidered state in which the disulfide has returned to the enzyme but unbinding and diffusion have not yet occurred.…”
Section: Figurementioning
confidence: 82%
See 2 more Smart Citations
“…Although PDI obtained near-unity amplitude as well, the fractional occurrence of reduced domains due to DsbA activity levels off at 0.44. We cite this observation as evidence of non-covalent interactions between unfolded substrate and enzyme, which have been described previously by others but remain poorly understood (17). The non-covalent interactions stabilize a previously unconsidered state in which the disulfide has returned to the enzyme but unbinding and diffusion have not yet occurred.…”
Section: Figurementioning
confidence: 82%
“…We note an especially striking disparity in the kinetics of non-oxidative release, a process that occurs with relative ease for PDI but is largely suppressed by DsbA. In a novel and expanded mechanistic model, we suggest that this arises from surprisingly strong enzyme-substrate non-covalent interactions, which have recently been documented but remain largely unexplained (17).…”
mentioning
confidence: 97%
See 1 more Smart Citation
“…Interestingly most of these translocated extracellular proteins in bacteria contain disulphide bonds which are introduced by oxidoreductase enzymes of the Dsb-family that share a conserved thioredoxin-type fold (9). The prototypical family member DsbA is necessary for the maturation of a range of virulence factors including flagellar motors and pilus adhesins, Type III secretion systems, and heat-labile and heat-stable enterotoxins and has emerged as a target for novel antibiotic development (10)(11)(12)(13). Notably, DsbA is an ongoing target for drug development due to its direct relevance in urinary tract infections, bacteremia, and biological weapons development (13)(14)(15)(16).…”
Section: Introductionmentioning
confidence: 99%
“…The inhibitory binding of EFTu to the non-catalytic surface of AbDsbA [82] presents the possibility of developing allosteric inhibitors that don't bind to the catalytic surface. This is a promising strategy for development of drugs for proteins such as CtDsbA that have no apparent pocket at the catalytic surface, but two pockets on the posterior surface.…”
Section: Future Perspectives For Developing Antimicrobial Drugs Targementioning
confidence: 99%